Chen Yueying, Shen Jun
Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Inflammatory Bowel Disease Research Center, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Institute of Digestive Disease, 160# Pu Jian Ave, Shanghai 200127, China.
EClinicalMedicine. 2022 Apr 7;46:101382. doi: 10.1016/j.eclinm.2022.101382. eCollection 2022 Apr.
The mission of the IBD Quality Care Evaluation Center (IBDQCC) is to establish indicators of quality of care (QoC), certify IBD units to generate a network of IBD quality care, and eventually improve the national level of IBD healthcare. The final list of 28 core and 13 secondary IBD QoC indicators suitable for the healthcare system in China were selected using a Delphi consensus methodology. Units that met all core indicators were qualified as "regional"; units that met all core indicators together with more than 50% of the secondary indicators received a rating of "excellence." Using the selected QoC core indicators for certifying IBD units, a network of IBD quality care units covering the majority of IBD patients in China was established.
This work was financially supported by Cultivation Funding for Clinical Scientific Research Innovation, Renji Hospital, School of Medicine, Shanghai Jiaotong University (RJPY-LX-004), National Natural Science Foundation of China (No. 81,770,545), Shanghai Science and Technology Innovation Initiative (21SQBS02302), and Cultivated Funding for Clinical Research Innovation, Renji Hospital, School of Medicine, Shanghai Jiaotong University (RJPY-LX-004).
炎症性肠病质量护理评估中心(IBDQCC)的任务是建立护理质量指标(QoC),认证炎症性肠病治疗单位以形成炎症性肠病质量护理网络,并最终提高全国炎症性肠病医疗水平。采用德尔菲共识法选取了适合中国医疗体系的28项核心和13项次要炎症性肠病QoC指标的最终清单。符合所有核心指标的单位被评为“区域级”;符合所有核心指标且次要指标超过50%的单位被评为“卓越级”。利用选定的QoC核心指标对炎症性肠病治疗单位进行认证,建立了覆盖中国大多数炎症性肠病患者的炎症性肠病质量护理单位网络。
本研究得到上海交通大学医学院附属仁济医院临床科研创新培育基金(RJPY-LX-004)、国家自然科学基金(81770545)、上海市科技创新行动计划(21SQBS02302)以及上海交通大学医学院附属仁济医院临床研究创新培育基金(RJPY-LX-004)的资助。